Lawrence W Greer Net Worth

The estimated Net Worth of Lawrence W Greer is at least $1.45 Milion dollars as of 16 March 2012. Lawrence Greer owns over 51,813 units of Cumberland Pharmaceuticals stock worth over $670,237 and over the last 15 years Lawrence sold CPIX stock worth over $776,996.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Lawrence Greer CPIX stock SEC Form 4 insiders trading

Lawrence has made over 4 trades of the Cumberland Pharmaceuticals stock since 2010, according to the Form 4 filled with the SEC. Most recently Lawrence sold 51,813 units of CPIX stock worth $399,996 on 16 March 2012.

The largest trade Lawrence's ever made was selling 65,000 units of Cumberland Pharmaceuticals stock on 21 November 2011 worth over $377,000. On average, Lawrence trades about 19,973 units every 95 days since 2010. As of 16 March 2012 Lawrence still owns at least 496,435 units of Cumberland Pharmaceuticals stock.

You can see the complete history of Lawrence Greer stock trades at the bottom of the page.

What's Lawrence Greer's mailing address?

Lawrence's mailing address filed with the SEC is 2525 WEST END AVE., SUITE 950, NASHVILLE, TN, 37203.

Insiders trading at Cumberland Pharmaceuticals

Over the last 15 years, insiders at Cumberland Pharmaceuticals have traded over $4,393,644 worth of Cumberland Pharmaceuticals stock and bought 265,077 units worth $1,208,228 . The most active insiders traders include Joey A Jacobs, Leo Pavliv a Thomas R Lawrence. On average, Cumberland Pharmaceuticals executives and independent directors trade stock every 29 days with the average trade being worth of $10,407. The most recent stock trade was executed by Caroline Young on 1 December 2022, trading 379 units of CPIX stock currently worth $849.

What does Cumberland Pharmaceuticals do?

cumberland pharmaceuticals is a specialty pharmaceutical company whose mission is to acquire currently marketed and late-stage development pharmaceutical products and grow them through marketing to targeted, underserved physician segments. cumberland is dedicated to providing high quality products which address unmet medical needs.

Complete history of Lawrence Greer stock trades at Cumberland Pharmaceuticals

Cumberland Pharmaceuticals executives and stock owners

Cumberland Pharmaceuticals executives and other stock owners filed with the SEC include:

• A. Kazimi,
  Chairman of the Board, Chief Executive Officer
• A. J. Kazimi,
  Founder, Chairman, Pres & CEO
• Leo Pavliv,
  Executive Vice President - Operations, Chief Development Officer
• Leo B. Pavliv,
  Exec. VP of Operations & Chief Devel. Officer
• Martin Cearnal,
  Executive Vice President, Chief Commercial Officer, Director
• Martin E. Cearnal,
  Exec. VP, Chief Commercial Officer & Director
• James Herman,
  Vice President - National Accounts, Chief Compliance Officer
• James Lowrance Herman,
  Sr. VP of National Accounts & Chief Compliance Officer
• Michael Bonner,
  Senior Director Finance and Accounting and Chief Financial Officer
• Caroline Young,
  Independent Director
• Kenneth Krogulski,
  Independent Director
• James Jones,
  Independent Director
• Joey Jacobs,
  Independent Director
• Jonathan Griggs,
  Independent Director
• Joseph Galante,
  Independent Director
• Gordon Bernard,
  Independent Director
• Erin Smith Gull,
  Sr. Corp. Relations Associate
• Adam S. Mostafa,
  Managing Director
• Cindy B. Patton,
  Sr. Director of Field Marketing
• Jean W. Marstiller,
  Sr. VP of Admin. Services & Corp. Sec.
• John Michael Hamm,
  Director of Fin. & Accounting and CFO
• Thomas R Lawrence,
  Director
• Martin S Jr Brown,
  
• Chris T. Bitterman,
  Vice Pres Sales & Marketing
• Rick Scott Greene,
  Chief Financial Officer
• Robert Edwards,
  Director
• Jean W Marstiller,
  Sr. VP & Corp. Secretary
• Lawrence W Greer,
  Director
• David L Lowrance,
  Vice President and CFO
• Todd M. Anthony,
  Vice Pres Organizational Dev
• John M. Hamm,
  VP Chief Financial Officer